Skip to content
No results
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact

Hello, feel free to inquire - up to 50% OFF!

dengyuemed logo
China Medicine Wholesaler
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
dengyuemed logo
China Medicine Wholesaler
china national essential medicines list 2026 key updates on innovative drugs, glp-1 and cancer therapies
News

China National Essential Medicines List 2026: Key Updates on Innovative Drugs, GLP-1 and Cancer Therapies

DengYueMed, DengYue 11/07/2026
eli lilly's imlunestrant approved in china oral serd offers a new treatment option for esr1-mutated breast cancer
News

Eli Lilly’s Imlunestrant Approved in China: Oral SERD Offers a New Treatment Option for ESR1-Mutated Breast Cancer

DengYueMed, DengYue 27/06/2026
silevimig approved for rabies passive immunization the first approved bispecific antibody for rabies prevention worldwide
News

Silevimig Approved for Rabies Passive Immunization: The First Approved Bispecific Antibody for Rabies Prevention Worldwide

DengYueMed, DengYue 26/06/2026
china approves the world's first car-t therapy for solid tumors satricabtagene autoleucel for cldn18.2-positive advanced gastric cancer
News

China Approves the World’s First CAR-T Therapy for Solid Tumors: Satricabtagene Autoleucel for CLDN18.2-Positive Advanced Gastric Cancer

DengYueMed, DengYue 24/06/2026
izalontamab brengitecan approved in china world's first egfr×her3 bispecific adc breakthrough in nasopharyngeal cancer
News

Izalontamab Brengitecan Approved in China: World’s First EGFR×HER3 Bispecific ADC, a Breakthrough in Nasopharyngeal Cancer

DengYueMed, DengYue 23/06/2026
the world’s second cfb inhibitor lanoracopan approved by nmpa china-developed pnh therapy marks a breakthrough
News

The World’s Second CFB Inhibitor Lanoracopan Approved by NMPA: China-Developed PNH Therapy Marks a Breakthrough

DengYueMed, DengYue 16/06/2026
gumokimab approved for plaque psoriasis in china the il-17a therapy landscape continues to evolve
News

Gumokimab Approved for Plaque Psoriasis in China: The IL-17A Therapy Landscape Continues to Evolve

DengYueMed, DengYue 12/06/2026
new hemophilia drug approved in china bemiltenase alfa becomes world’s first factor x activator
News

New Hemophilia Drug Approved in China: Bemiltenase Alfa Becomes World’s First Factor X Activator

DengYueMed, DengYue 05/06/2026
may 2026 china innovative drug approvals 5 major new drugs approved
News

May 2026 China Innovative Drug Approvals: 5 Major New Drugs Approved

DengYueMed, DengYue 03/06/2026
nipocalimab approved in china for generalized myasthenia gravis with long term stable disease control emerging as a key highlight
News

Nipocalimab Approved in China for Generalized Myasthenia Gravis, With Long-Term Stable Disease Control Emerging as a Key Highlight

DengYueMed, DengYue 27/05/2026
epcoritamab approved in china for follicular lymphoma bringing a new cd20×cd3 bispecific therapy option
News

Epcoritamab Approved in China for Follicular Lymphoma, Bringing a New CD20×CD3 Bispecific Therapy Option

DengYueMed, DengYue 19/05/2026
china innovative drug approvals april 2026 6 approved 5 by chinese companies
News

China Innovative Drug Approvals April 2026: 6 Approved, 5 by Chinese Companies

DengYueMed, DengYue 07/05/2026
Quick Links
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
  • Home
  • Pharmacies and Hospitals
  • pharmaceutical-wholesaler
  • Oncology Diseases
  • Products
  • Articles
    • News
    • Blog
    • QA
    • Patient Guide
  • About Us
  • Contact
Get In Touch
  • Phone: +852-56986617
  • Whats APP: +852-56986617
  • Fax: +852-56986617
  • Email: inquiry@dengyuemed.com
  • Address: 6/F, Tai Tak Industrial Building, New Territories, Hong Kong
X-twitter Facebook Youtube Linkedin Instagram

Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights

WhatsApp us